Impact of pharmacokinetic (PK) and microbiological variability on the pharmacodynamics of gatifloxacin (GAT) against S. pneumoniae in children
Impact of pharmacokinetic (PK) and microbiological variability on the pharmacodynamics of gatifloxacin (GAT) against S. pneumoniae in children, Lead author: Rubino CM, presented at 42nd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2002, San Diego, California